Seroprevalence of West Nile virus antibodies in blood donors living in the metropolitan area of Milan, Italy, 2009-2011.

Paolo Gaibani(University of Verona), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Claudio Farina(Istituto Superiore di Sanità), Vincenzo Toschi(Ospedale San Carlo), Caterina Matinato(IRCCS Policlinico San Donato), Antonella Zoccoli(IRCCS Policlinico San Donato), Erminio Torresani(Istituto Superiore di Sanità), G. Lunghi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Anna Orlandi(IRCCS Policlinico San Donato), Maria Paola Landini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Anna Pierro(University of Bologna), D. Almini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
PubMed
January 1, 2013
Cited by 12

Related Papers

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
|medRxiv|2020|234
West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention
|Clinical Microbiology and Infection|2013|210
Isolation of Usutu Virus in Germany
|American Journal of Tropical Medicine and Hygiene|2011|200
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009
|Eurosurveillance|2009|200
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
|Hepatology|1997|178